(Q52006420)

19 April 2018

title

Moclobemide versus fluoxetine for double depression: a randomized double-blind study. (English)

1 reference

19 April 2018

1 reference

1 reference

Duarte A

1

1 reference

19 April 2018

Mikkelsen H

series ordinal

2

1 reference

19 April 2018

Delini-Stula A

series ordinal

3

1 reference

19 April 2018

publication date

1 November 1996

1 reference

19 April 2018

Journal of Psychiatric Research

published in

1 reference

19 April 2018

volume

30

1 reference

19 April 2018

page(s)

453-458

1 reference

19 April 2018

issue

6

1 reference

19 April 2018

A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Long-term treatment of double depression: a preliminary study with serotonergic antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

"Double depression": two-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Imipramine treatment for chronic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Pharmacological therapy of dysthymia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Moclobemide — Placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

inferred from DOI database lookup

7 January 2021

based on heuristic

A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2896%2900030-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(96)00030-1

1 reference

19 April 2018

PubMed ID

9023788

1 reference

19 April 2018